First Light Asset Management, LLC Global Blood Therapeutics, Inc. Transaction History

First Light Asset Management, LLC

  • $1.15 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$52.76 - $74.49 $15.5 Million - $21.9 Million
-294,316 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$48.73 - $81.82 $13.8 Million - $23.2 Million
283,016 Added 2504.57%
294,316 $18.6 Million
Q1 2020

May 15, 2020
SELL
$41.72 - $87.2 $112,644 - $235,440
-2,700 Reduced 19.29%
11,300 $577,000
Q4 2019

Feb 14, 2020
BUY
$45.7 - $81.86 $639,800 - $1.15 Million
14,000 New
14,000 $1.11 Million

Others Institutions Holding GBT

# of Institutions
8
Shares Held
288K
Call Options Held
0
Put Options Held
0
View Full List

About Global Blood Therapeutics, Inc.

GBT Quotes by TradingView
  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track First Light Asset Management, LLC Portfolio

Follow First Light Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Light Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email